Observational study that will evaluate treatment patterns in the management of hypertension in various scenarios in the public primary care system - CLEAR-HTN

Study identifier:D6970R00015

ClinicalTrials.gov identifier:NCT07361276

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

Clinical Landscape of Epidemiology and Assessment of Results in hypertension

Medical condition

hypertension

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

15000

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 31 Dec 2025
Estimated Primary Completion Date: 31 Jul 2026
Estimated Study Completion Date: 31 Jul 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2025 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria